Alto Neuroscience, Inc. (NYSE:ANRO) Receives Average Rating of "Moderate Buy" from Analysts
Alto Neuroscience, Inc. (NYSE:ANRO - Get Free Report) has been assigned an average recommendation of "Moderate Buy" from the eight ratings firms that are covering the company, MarketBeat reports. One...